1 – 20 of 120
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
(
- Contribution to journal › Article
-
Mark
Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair
2023) In Clinical cancer research : an official journal of the American Association for Cancer Research 29(22). p.4644-4659(
- Contribution to journal › Article
-
Mark
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial
2023) In Clinical cancer research : an official journal of the American Association for Cancer Research 29(24). p.5057-5068(
- Contribution to journal › Article
-
Mark
Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
(
- Contribution to journal › Article
- 2022
-
Mark
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation
(
- Contribution to journal › Article
-
Mark
B Cells and Tertiary Lymphoid Structures : Friends or Foes in Cancer Immunotherapy?
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Hypofractionated FLASH-RT as an effective treatment against glioblastoma that reduces neurocognitive side effects in mice
(
- Contribution to journal › Article
-
Mark
Immune infiltrate in the primary tumor predicts effect of adjuvant radiotherapy in breast cancer : Results from the randomized SweBCG91RT trial
(
- Contribution to journal › Article
-
Mark
PSA-Targeted Alpha-, Beta-, and Positron-emitting immunotheranostics in murine prostate cancer models and nonhuman primates
(
- Contribution to journal › Article
-
Mark
An Open Source, Automated Tumor Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy
(
- Contribution to journal › Article
- 2019
-
Mark
Harnessing androgen receptor pathway activation for targeted alpha particle radioimmunotherapy of breast cancer
(
- Contribution to journal › Article
-
Mark
Proteogenomic characterization of patient-derived xenografts highlights the role of REST in neuroendocrine differentiation of castration-resistant prostate cancer
(
- Contribution to journal › Article
-
Mark
Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma
(
- Contribution to journal › Article
-
Mark
New Hope in Prostate Cancer Precision Medicine? miRNA Replacement and Epigenetics
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort.
(
- Contribution to journal › Article
-
Mark
Integrated molecular analysis of undifferentiated uterine sarcomas reveals clinically relevant molecular subtypes
(
- Contribution to journal › Article
-
Mark
Transcriptomic analysis reveals prognostic molecular signatures of stage I melanoma
(
- Contribution to journal › Article
-
Mark
The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients
(
- Contribution to journal › Article
-
Mark
BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
2019) In Clinical cancer research : an official journal of the American Association for Cancer Research 25(23). p.7139-7150(
- Contribution to journal › Article